Search

The Australian Brain Cancer Landscape 2025

HomeResourcesThe Australian Brain Cancer Landscape 2025

Brain cancer remains one of the most complex and devastating diseases impacting Australians.

Biointelect supported Brain Tumour Alliance Australia (BTAA) in developing the landmark report the Australian Brain Cancer Landscape 2025. This paper provides government, policymakers, and the broader community with a clear, evidence-based picture of brain cancer in Australia.

It highlights the profound health, economic, and social burden of brain cancer on patients, families, communities, and government. The paper examines the current state of research and clinical trials, clinical care, and support services and calls for urgent action across these three critical pillars, to improve outcomes for Australians diagnosed with brain cancer.

Biointelect conducted the underlying burden of disease analysis to establish a robust evidence base and engaged key stakeholders to create a comprehensive view of the current landscape.

Endorsed by the nine organisations that form the Australian Brain Tumour Collaborative (ABTC), the report was officially launched on 28 October 2025 at BTAA’s annual Head to the Hill event at Parliament House.

For a summary of the Australian Brain Cancer Landscape 2025, please access the summary paper.

Related Resources

Want To Find Out More?

Are you interested in learning more about Biointelect, including our current white paper submissions and health policy related work?

Get in touch with our team to discover how we’re advancing healthcare for all and how you can harness our intellect and proven expertise in bringing innovative life science to market.

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.